Literature DB >> 14738815

Energy intake and obesity in Japanese patients with type 2 diabetes.

Hirohito Sone, Yukio Yoshimura, Hideki Ito, Yasuo Ohashi, Nobuhiro Yamada.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14738815     DOI： 10.1016/S0140-6736(03)15348-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Current lifestyle factors that increase risk of T2DM in China.

Authors:  N Zhang; S M Du; G S Ma
Journal:  Eur J Clin Nutr       Date:  2017-04-19       Impact factor: 4.016

2.  Dietary Polysaccharides in the Amelioration of Gut Microbiome Dysbiosis and Metabolic Diseases.

Authors:  Shokouh Ahmadi; Rabina Mainali; Ravinder Nagpal; Mahmoud Sheikh-Zeinoddin; Sabihe Soleimanian-Zad; Shaohua Wang; Gagan Deep; Santosh Kumar Mishra; Hariom Yadav
Journal:  Obes Control Ther       Date:  2017-12-18

3.  Cohort profile: The Japan diabetes complications study: a long-term follow-up of a randomised lifestyle intervention study of type 2 diabetes.

Authors:  Shiro Tanaka; Sachiko Tanaka; Satoshi Iimuro; Hidetoshi Yamashita; Shigehiro Katayama; Yasuo Ohashi; Yasuo Akanuma; Nobuhiro Yamada; Hirohito Sone
Journal:  Int J Epidemiol       Date:  2013-05-18       Impact factor: 7.196

4.  Metabolic syndrome is not a predictor for cardiovascular events in Japanese patients with diabetes mellitus asymptomatic for coronary artery disease: a retrospective analysis of the J-ACCESS-2 study.

Authors:  Kenichi Nakajima; Yasuchika Takeishi; Shinro Matsuo; Yoshimitsu Yamasaki; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2012-11-30       Impact factor: 5.952

5.  Intakes of dietary fiber, vegetables, and fruits and incidence of cardiovascular disease in Japanese patients with type 2 diabetes.

Authors:  Shiro Tanaka; Yukio Yoshimura; Chiemi Kamada; Sachiko Tanaka; Chika Horikawa; Ryota Okumura; Hideki Ito; Yasuo Ohashi; Yasuo Akanuma; Nobuhiro Yamada; Hirohito Sone
Journal:  Diabetes Care       Date:  2013-10-29       Impact factor: 19.112

6.  Dietary intake in Japanese patients with type 2 diabetes: Analysis from Japan Diabetes Complications Study.

Authors:  Chika Horikawa; Yukio Yoshimura; Chiemi Kamada; Shiro Tanaka; Sachiko Tanaka; Akane Takahashi; Osamu Hanyu; Atsushi Araki; Hideki Ito; Akira Tanaka; Yasuo Ohashi; Yasuo Akanuma; Nobuhiro Yamada; Hirohito Sone
Journal:  J Diabetes Investig       Date:  2013-12-01       Impact factor: 4.232

7.  Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study).

Authors:  H Sone; S Tanaka; S Iimuro; S Tanaka; K Oida; Y Yamasaki; S Oikawa; S Ishibashi; S Katayama; H Yamashita; H Ito; Y Yoshimura; Y Ohashi; Y Akanuma; N Yamada
Journal:  Diabetologia       Date:  2010-01-07       Impact factor: 10.122

8.  Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine.

Authors:  Shiro Tanaka; Sachiko Tanaka; Satoshi Iimuro; Hidetoshi Yamashita; Shigehiro Katayama; Yasuo Akanuma; Nobuhiro Yamada; Atsushi Araki; Hideki Ito; Hirohito Sone; Yasuo Ohashi
Journal:  Diabetes Care       Date:  2013-02-12       Impact factor: 19.112

9.  Do body mass index trajectories affect the risk of type 2 diabetes? A case-control study.

Authors:  Yoshihiko Mano; Hiroshi Yokomichi; Kohta Suzuki; Atsunori Takahashi; Yoshioki Yoda; Masahiro Tsuji; Miri Sato; Ryoji Shinohara; Sonoko Mizorogi; Mie Mochizuki; Zentaro Yamagata
Journal:  BMC Public Health       Date:  2015-07-28       Impact factor: 3.295

10.  Past Obesity as well as Present Body Weight Status Is a Risk Factor for Diabetic Nephropathy.

Authors:  Shu Meguro; Yusuke Kabeya; Karin Tanaka; Toshihide Kawai; Masuomi Tomita; Takeshi Katsuki; Yoichi Oikawa; Yoshihito Atsumi; Akira Shimada; Masami Tanaka; Junichiro Irie; Yoshifumi Saisho; Hiroshi Itoh
Journal:  Int J Endocrinol       Date:  2013-08-26       Impact factor: 3.257
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.